INSULIN-LIKE GROWTH FACTOR INCREASED

This adverse event was reported 1427 times

These drugs are most commonly taken by patients reporting INSULIN-LIKE GROWTH FACTOR INCREASED:

# Drug Count
0 SOMATROPIN 390
1 PEGVISOMANT 380
2 OCTREOTIDE ACETATE 293
3 LEVOTHYROXINE SODIUM 120
4 LANREOTIDE ACETATE 101
5 METFORMIN 95
6 HYDROCORTISONE 93
7 CABERGOLINE 86
8 METFORMIN ER 500 MG 84
9 METFORMIN ER 750 MG 84
See all common drugs associated with INSULIN-LIKE GROWTH FACTOR INCREASED

INSULIN-LIKE GROWTH FACTOR INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGVISOMANT 380 0.0925
1 PALTUSOTINE 8 0.0336
2 CABERGOLINE 86 0.0175
3 SOMAPACITAN-BECO 3 0.0166
4 LANREOTIDE ACETATE 101 0.0127
5 PASIREOTIDE 26 0.0115
6 OCTREOTIDE ACETATE 293 0.0095
7 MECASERMIN 7 0.0086
8 SOMATROPIN 390 0.0052
9 TESAMORELIN 8 0.0047
See all drugs enriched for association with INSULIN-LIKE GROWTH FACTOR INCREASED

INSULIN-LIKE GROWTH FACTOR INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 86 0.0175
1 Recombinant Human Growth Hormone [EPC] 138 0.0063
2 Somatostatin Analog [EPC] 38 0.0055
3 Carnitine Analog [EPC] 9 0.0024
4 Provitamin D2 Compound [EPC] 64 0.0022
5 Androgen [EPC] 42 0.0015
6 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 3 0.0005
7 Stimulant Laxative [EPC] 5 0.0003
8 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
9 Aromatase Inhibitor [EPC] 26 0.0002
See all drug classes enriched for association with INSULIN-LIKE GROWTH FACTOR INCREASED